Evidence map›Paper›PMID 35961720›Full record

ReviewCanadian family physician Medecin de famille canadien2022

Overview of hemodialysis access and assessment.

Rohan Arasu, Dev Jegatheesan, Yogeesan Sivakumaran

Abstract readReview
In one paragraph

Review in Canadian family physician Medecin de famille canadien, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rohan ArasuRegistrar in the Department of Vascular Surgery at Fiona Stanley Hospital and Associate Lecturer in the Faculty of Medicine at the University of Queensland in Brisbane, Australia.
Dev JegatheesanNephrologist in the Department of Nephrology at Princess Alexandra Hospital and Lecturer in the Centre for Kidney Disease Research at the University of Queensland.
Yogeesan SivakumaranVascular surgeon in the Department of Vascular Surgery at Princess Alexandra Hospital and Senior Lecturer in the School of Clinical Medicine at the University of Queensland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo provide family physicians with an evidence-based overview on the various methods of vascular access for hemodialysis (HD) and to provide a framework for the clinical assessment of HD access. SOURCES OF INFORMATION: A MEDLINE literature search was conducted using the MeSH terms MAIN MESSAGE: The main types of permanent vascular access for HD are arteriovenous fistulas, arteriovenous grafts, and central venous catheters. A pragmatic, patient-centred approach is required when choosing the type of access for an individual. Common complications of vascular access creation include thrombosis, central venous stenosis, dialysis access steal syndrome, and arteriovenous fistula aneurysms.

conclusionFamily physicians play an important role in the clinical assessment and monitoring of HD vascular access. A thorough clinical assessment can detect a failing arteriovenous fistula and any associated complications, which can allow for prompt investigation and intervention to restore functionality, maintain access longevity, and improve patient quality of life.

Indexed as

Arteriovenous FistulaArteriovenous Shunt, SurgicalCentral Venous CathetersHumansQuality of LifeRenal DialysisTreatment Outcome

Identifiers

PMID35961720
PMCPMC9374077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.